Evaxion A/S Share Price
NASDAQ: EVAXEvaxion A/S Stock Performance
Evaxion A/S Share Price Today
As of 10 October 2026, Evaxion A/S's share price is $3.04. The stock opened at $3.10, compared to its previous close of $3.22. During today's trading session, Evaxion A/S's share price traded between $3.02 and $3.10, with an average price of $3.06. Over the past 52 weeks, the stock has recorded a high of $11.66 and a low of $2.79. In terms of performance, Evaxion A/S's share price has declined by 28.69% over the last six months and is down 47.59% on a year-on-year basis.
Evaxion A/S Share Price Chart
Evaxion A/S Annual Profit & Loss
All figures in USD
About Evaxion A/S
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Evaxion A/S Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.21 | $3.05 | -6.15% |
Sep 2026 | $2.97 | $3.25 | +2.52% |
Aug 2026 | $2.79 | $3.17 | +11.62% |
Jul 2026 | $3.06 | $2.84 | -9.55% |
Jun 2026 | $3.85 | $3.14 | -23.79% |
May 2026 | $4.48 | $4.12 | -3.51% |
Apr 2026 | $3.73 | $4.27 | +19.94% |
Mar 2026 | $3.20 | $3.56 | +10.22% |
Feb 2026 | $3.15 | $3.23 | +2.22% |
Jan 2026 | $4.84 | $3.16 | -34.30% |
Dec 2025 | $5.54 | $4.81 | -19.83% |
Nov 2025 | $5.79 | $6.00 | +3.27% |